HERON THERAPEUTICS, INC. /DE/ (HRTX) Capital expenditures 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$317,000FY2025 · since FY2016: $3.1M → $317,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $317,000 | -81.4% |
| FY2024 | $1.7M | +10.4% |
| FY2023 | $1.5M | -15.3% |
| FY2022 | $1.8M | -39.6% |
| FY2021 | $3.0M | -55.6% |
| FY2020 | $6.8M | -4.8% |
| FY2019 | $7.2M | -22.0% |
| FY2018 | $9.2M | +259.2% |
| FY2017 | $2.6M | -18.6% |
| FY2016 | $3.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice